Ocrelizumab shows game-changing results in major trials assessing its efficacy in treating MS.
Exciting news regarding this possible new treatment claimed to halt the progression of this neurological disease.
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.